comparemela.com

Colon Next Gen News Today : Breaking News, Live Updates & Top Stories | Vimarsana

EQS-Adhoc: Epigenomics AG: Closing of Agreement on the Acquisition of Almost All Assets and Adjustment of Guidance for 2023

EQS-Ad-hoc: Epigenomics AG / Key word(s): Contract/Disposal Epigenomics AG: Closing of Agreement on the Acquisition of Almost All.

Day diagnosticsAlmost all assetsFrankfurt general standardNew day diagnosticsNew dayColon next genFrederic hilke

EQS-News: Epigenomics AG publishes financial results for the first six months 2023

EQS-News: Epigenomics AG / Key word(s): Half Year Report/Half Year Results Epigenomics AG publishes financial resu.

Helge lubenowDay diagnosticsMazars gmbh coCompany supervisory boardExecutive boardNew day diagnosticsSupervisory boardExtraordinary general shareholder meetingColon next genMazars gmbhFairness opinionsGerman institutePublic auditorsInvestor relationsFrederic hilke

EQS-Adhoc: Epigenomics AG: Agreement on the Acquisition of Almost All Assets

EQS-Adhoc: Epigenomics AG: Agreement on the Acquisition of Almost All Assets
finanzen.ch - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanzen.ch Daily Mail and Mail on Sunday newspapers.

German stock corporationDay diagnosticsAlmost allFrankfurt prime standardNew day diagnosticsGerman stock corporation actColon next genFrederic hilke

Epigenomics AG plans to issue mandatory convertible bond in the amount of up to EUR 18 15 million

11.06.2021 Epigenomics AG plans to issue mandatory convertible bond in the amount of up to EUR 18.15 million | Epigenomics AG | News | Nachricht | Mitteilung

United statesFabian kirchmannDrug administrationExecutive boardFrankfurt prime standardSupervisory boardDeutsche balaton aktiengesellschaftFederal gazetteColon next genUnited statesaFrederic hilkeD hocஒன்றுபட்டது மாநிலங்களில்நிர்வாகி பலகைபிராங்க்ஃபர்ட் ப்ரைம் தரநிலைமேற்பார்வை பலகை

vimarsana © 2020. All Rights Reserved.